0001396677-11-000024.txt : 20110602 0001396677-11-000024.hdr.sgml : 20110602 20110602202724 ACCESSION NUMBER: 0001396677-11-000024 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110602 FILED AS OF DATE: 20110602 DATE AS OF CHANGE: 20110602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seelos Andrew W CENTRAL INDEX KEY: 0001396677 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23731 FILM NUMBER: 11890031 MAIL ADDRESS: STREET 1: C/O NUTRACEUTICAL CORPORATION STREET 2: 1400 KEARNS BOULEVARD, 2ND FLOOR CITY: PARK CITY STATE: X1 ZIP: 84060 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP CENTRAL INDEX KEY: 0001050007 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870515089 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 BUSINESS PHONE: 4356556000 MAIL ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0303 4/A 2011-06-02 2011-06-02 0 0001050007 NUTRACEUTICAL INTERNATIONAL CORP NUTR 0001396677 Seelos Andrew W C/O NUTRACEUTICAL CORPORATION 1400 KEARNS BOULEVARD, 2ND FLOOR PARK CITY X1 84060 UNITED STATES 0 1 0 0 Asst VP & Controller Common Stock 2011-06-02 4 A 0 130.89 15.28 A 14673.082 D The purchase reported in this Form 4 was effected pursuant to an enrollment plan under the issuer's Stock Purchase Plan for Employees, Stakeholders and Shareholders adopted by the reporting person on March 20, 2008. Correction of amount of securities beneficially owned. /s/ Alison Pitt, attorney in fact 2011-06-02